Ogn | osteoglycin
Physiological systems
18 / 24 physiological systems tested
5 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Hematopoietic system Behavior/neurological Cardiovascular system
13 No significant impact
6 Not tested
Data collections
Gene metrics:4Significant phenotypes
0Associated diseases
Expression examined in:48Adult tissues
52Embryo tissues
decreased leukocyte cell number | 1 supporting dataset | Ogntm1b(KOMP)Wtsi | homozygote | Early adult | 2.83x10-6 | ||
hyperactivity | 1 supporting dataset | Ogntm1b(KOMP)Wtsi | homozygote | Early adult | 1.03x10-5 | ||
prolonged RR interval | 1 supporting dataset | Ogntm1b(KOMP)Wtsi | homozygote | Early adult | 3.62x10-5 | ||
increased fasting circulating glucose level | 1 supporting dataset | Ogntm1b(KOMP)Wtsi | homozygote | Early adult | 6.98x10-5 |
| | | | | | | | | |
External links
No external links available for Ogn.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Ogntm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Ogntm1b(KOMP)Wtsi | Reporter-tagged deletion allele (with selection cassette) | | mouse |
Ogntm1e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell |